HALO
Halozyme Therapeutics, Inc. · Healthcare
SVP and Chief Technical Officer Michael J. Labarre sold $484K of Halozyme Therapeutics, Inc.
Sold$483,940
$48.39Price
10,000Shares
−6%Stake
What HALO did after the filing
- The stock from Fri, Feb 17 open, $49.48
- −21.7%
- S&P 500, same days
- +1.6%
Measured over 30 trading days, to the Apr 3 close.
Traded Wed, Feb 15. Filed Fri, Feb 17, 1:29 AM ET, before the open. Returns use the Feb 17 open and the Apr 3 close. Not investment advice.